Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kevin Rakin currently holds 4,978,978 shares of ORAMED PHARMACEUTICALS INC. (ORMP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kevin Rakin has been a net seller of ORMP stock. They have purchased $174.8K and sold $890.3K worth of shares.
Kevin Rakin's most recent insider trade was on Dec 11, 2025, when they sold 4,372,497 shares at $0.00 per share.
Kevin Rakin serves as Executive at ORAMED PHARMACEUTICALS INC. (ORMP). They have executed 65 insider transactions totaling $1.1M over their tenure at the company.
Kevin Rakin holds the position of Executive at ORAMED PHARMACEUTICALS INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Kevin Rakin has shown a selling trading pattern, with $174.8K in total purchases and $890.3K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Kevin Rakin was on Jun 10, 2021, when they purchased $19.0M worth of QSI shares. This transaction involved 1,901,000 shares at $10.00 per share.
Kevin Rakin currently owns 4,978,978 shares of ORAMED PHARMACEUTICALS INC. (ORMP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kevin Rakin's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kevin Rakin has 65 Form 4 filings on record as an insider at ORAMED PHARMACEUTICALS INC..
Set alerts for Kevin Rakin and 40,000+ other insiders.